Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-29

Clinical Trial Update: Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer [NA]

View source ↗

Summary

Clinical trial update reporting efficacy evaluation of TheraSphere after failed first-line chemotherapy in metastatic colorectal cancer; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Colorectal Cancer Metastatic | NA | Status: COMPLETED | Results posted: 2022-03-29